These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 19086090)

  • 1. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals.
    Seeman P
    Synapse; 2009 Mar; 63(3):186-92. PubMed ID: 19086090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L; Wilson AA; Garcia A; Houle S; Kapur S; Ginovart N
    Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
    McCormick PN; Kapur S; Seeman P; Wilson AA
    Nucl Med Biol; 2008 Jan; 35(1):11-7. PubMed ID: 18158938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo vulnerability to competition by endogenous dopamine: comparison of the D2 receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]-raclopride.
    Narendran R; Hwang DR; Slifstein M; Talbot PS; Erritzoe D; Huang Y; Cooper TB; Martinez D; Kegeles LS; Abi-Dargham A; Laruelle M
    Synapse; 2004 Jun; 52(3):188-208. PubMed ID: 15065219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonist radioligand binds to both D2High and D2Low receptors, explaining why alterations in D2High are not detected in human brain scans.
    Seeman P
    Synapse; 2012 Jan; 66(1):88-93. PubMed ID: 21954082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased dopamine D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO.
    Seeman P; McCormick PN; Kapur S
    Synapse; 2007 May; 61(5):263-7. PubMed ID: 17318886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of unilateral 6-OHDA lesions on [3H]-N-propylnorapomorphine binding in striatum ex vivo and vulnerability to amphetamine-evoked dopamine release in rat.
    Palner M; Kjaerby C; Knudsen GM; Cumming P
    Neurochem Int; 2011 Feb; 58(3):243-7. PubMed ID: 21163313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron-labeled dopamine agonists for probing the high affinity states of dopamine subtype 2 receptors.
    Hwang DR; Narendran R; Laruelle M
    Bioconjug Chem; 2005; 16(1):27-31. PubMed ID: 15656572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
    Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
    Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
    J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2(High) receptors and marked supersensitivity to the dopamine agonist (+)PHNO.
    Seeman P; Battaglia G; Corti C; Corsi M; Bruno V
    Synapse; 2009 Mar; 63(3):247-51. PubMed ID: 19084908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex vivo [11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro.
    McCormick PN; Kapur S; Reckless G; Wilson AA
    Synapse; 2009 Nov; 63(11):998-1009. PubMed ID: 19598174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
    Kiss B; Horti F; Bobok A
    Synapse; 2011 Jun; 65(6):467-78. PubMed ID: 20936685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges.
    Seeman P; Tallerico T; Ko F; Tenn C; Kapur S
    Synapse; 2002 Dec; 46(4):235-9. PubMed ID: 12373738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
    Seeman P; Tallerico T; Ko F
    Synapse; 2003 Sep; 49(4):209-15. PubMed ID: 12827639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
    Seeman P; Ko F; Willeit M; McCormick P; Ginovart N
    Synapse; 2005 Nov; 58(2):122-8. PubMed ID: 16088951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to dopamine receptors in living mouse striatum: occupancy by endogenous dopamine and guanosine triphosphate-free G protein.
    Cumming P; Wong DF; Gillings N; Hilton J; Scheffel U; Gjedde A
    J Cereb Blood Flow Metab; 2002 May; 22(5):596-604. PubMed ID: 11973432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Dopamine D2 Receptor Agonist, [
    Subburaju S; Sromek AW; Seeman P; Neumeyer JL
    ACS Chem Neurosci; 2018 Jun; 9(6):1283-1289. PubMed ID: 29641175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist binding fraction of dopamine D2/3 receptors in rat brain: a quantitative autoradiographic study.
    Minuzzi L; Cumming P
    Neurochem Int; 2010; 56(6-7):747-52. PubMed ID: 20117160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.